BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 1, 2025
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
Ciba Vision licenses novel antiglaucoma agent from Ueno
Oct. 25, 1996
Revolutionary treatment for nearsightedness enters pivotal trials
Oct. 18, 1996
Sugen-Allergen collaboration in ophthalmic diseases
Oct. 18, 1996
New use for Uriach's rupatadine
Oct. 11, 1996
Anticataract and NGF production-enhancing compounds
Sep. 27, 1996
Wakamoto claims diclofenac eyedrop formulation
Sep. 20, 1996
AGN-193080, a peripherally acting alpha2-agonist from Allergan
Sep. 20, 1996
Xalatan Solution now available for glaucoma
Sep. 20, 1996
U.S. approval for glaucoma medication
Sep. 13, 1996
Potent antiinflammatory/antioxidant agents from Alcon
Aug. 30, 1996
Previous
1
2
…
379
380
381
382
383
384
385
386
387
Next